Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
about
Diabetes mellitus related bone metabolism and periodontal diseasePathogenesis of diabetic cerebral vascular disease complicationPlasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study.Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?Comparing the disease profiles of adult patients with type 2 diabetes mellitus attending four public health care facilities in MalaysiaSoluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials.Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventionsCystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.Tight glycemic control and cardiovascular effects in type 2 diabetic patients.Quality improvement in diabetes--successful in achieving better care with hopes for prevention.Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil.Unfavorable neurological outcome in diabetic patients with acute ischemic stroke is associated with incomplete recanalization after intravenous thrombolysis.Oral manifestations of Diabetes Mellitus. A systematic review.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.Challenges in the treatment of hypertriglyceridemia: glass half empty or half full?rich in 3, 5-/4, 5-dicaffeoylquinic acid and chlorogenic acid reduces islet cell apoptosis and improves pancreatic function in type 2 diabetic mice
P2860
Q26852990-9A45CCC1-1210-4C2A-B4AA-EDDEA802E911Q28087462-B9CAC9CE-9A3C-43D1-87C4-1399B71A2264Q34347027-8A430136-861A-44D4-9333-AD171C8BE5ECQ35179226-C287C141-156B-4096-872E-B760A7DDE211Q35454400-C7950EC9-A73E-48FC-A87F-BD011D015D55Q36000012-B762BEA2-59E1-4B8E-BB0D-2A05877D2774Q37023878-B6AD52C6-A7EA-4945-83D0-BBA75CC020ADQ37192024-B91B5E14-DB3E-4EE7-BD22-907D764E5BF7Q37320802-0F0FBF60-5DD4-42A5-89A1-D9974A6A47FFQ37660880-7008922B-B129-46C2-BDEC-9C486D4F0922Q38379445-E17E7F03-7E46-419F-BB90-DD180F9A39E0Q38614811-D973055A-2F06-46A5-AD15-1CEDFB8E63C2Q40912448-FE1DD92E-DEF2-40DF-BAA0-61FA74D7A87CQ41307905-E197EB2C-983E-469D-AEB8-A1383EFB482DQ42005662-705F363E-C6C8-43ED-A821-8B742DDFEB56Q47557757-32527E9F-5F03-4ED2-B1CF-3CAABFDDFE33Q51301866-162CA9A5-E3FE-4DA5-8EC1-9728DF3FB72EQ58577338-3F172EF4-7E40-4268-9AF1-6B73314728B5
P2860
Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@en
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@nl
type
label
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@en
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@nl
prefLabel
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@en
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@nl
P2093
P2860
P1476
Pharmacologic prevention of mi ...... cal trials in type 2 diabetes.
@en
P2093
K M Venkat Narayan
Mohammed K Ali
Nikhil Tandon
P2860
P356
10.2165/11594650-000000000-00000
P577
2012-02-01T00:00:00Z
P6179
1006384745